サマリー

顔面紅斑の治療薬
市場の分析と洞察。顔面紅斑用医薬品の世界市場
COVID-19の流行により、顔面紅斑用医薬品の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年に顔面紅斑用薬剤の世界市場の％を占めたRxは、2028年までに100万米ドルの価値を持ち、COVID-19以降の期間に修正された％のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して％CAGRに変更されています。

中国の顔面紅斑用薬剤の市場規模は2021年に100万米ドル、米国と欧州の顔面紅斑用薬剤はそれぞれ100万米ドル、100万米ドルとされています。2021年の米国の割合は％、中国と欧州はそれぞれ％、％であり、中国の割合は2028年には％に達すると予測され、分析期間を通じてCAGRは％を推移しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパの顔面紅斑用薬剤の展望としては、ドイツが2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。
顔面紅斑治療薬の世界の主要メーカーは、Novartis、Pfizer、Sanofi-Aventis、Merck、Enzon Pharmaceuticals、Bayer、Astellas Pharma、GSKおよびAbbottなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。

世界の顔面紅斑用医薬品の範囲とセグメント
顔面紅斑治療薬市場は、タイプ別と用途別に分類されます。世界の顔面紅斑治療薬市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
Rx
一般用医薬品
用途別セグメント
病院
クリニック
その他

会社別
ノバルティス
ファイザー
サノフィ・アベンティス
メルク
エンゾン・ファーマシューティカルズ
バイエル
アステラス製薬
GSK
アボット

地域別
北米
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Drugs for Facial Erythema Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Facial Erythema Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Rx
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Drugs for Facial Erythema Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs for Facial Erythema Sales Estimates and Forecasts 2017-2028
2.2 Global Drugs for Facial Erythema Revenue Estimates and Forecasts 2017-2028
2.3 Global Drugs for Facial Erythema Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drugs for Facial Erythema Sales by Region
2.4.1 Global Drugs for Facial Erythema Sales by Region (2017-2022)
2.4.2 Global Sales Drugs for Facial Erythema by Region (2023-2028)
2.5 Global Drugs for Facial Erythema Revenue by Region
2.5.1 Global Drugs for Facial Erythema Revenue by Region (2017-2022)
2.5.2 Global Drugs for Facial Erythema Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drugs for Facial Erythema Sales by Manufacturers
3.1.1 Global Top Drugs for Facial Erythema Manufacturers by Sales (2017-2022)
3.1.2 Global Drugs for Facial Erythema Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drugs for Facial Erythema in 2021
3.2 Global Drugs for Facial Erythema Revenue by Manufacturers
3.2.1 Global Drugs for Facial Erythema Revenue by Manufacturers (2017-2022)
3.2.2 Global Drugs for Facial Erythema Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drugs for Facial Erythema Revenue in 2021
3.3 Global Drugs for Facial Erythema Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drugs for Facial Erythema Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drugs for Facial Erythema Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drugs for Facial Erythema Sales by Type
4.1.1 Global Drugs for Facial Erythema Historical Sales by Type (2017-2022)
4.1.2 Global Drugs for Facial Erythema Forecasted Sales by Type (2023-2028)
4.1.3 Global Drugs for Facial Erythema Sales Market Share by Type (2017-2028)
4.2 Global Drugs for Facial Erythema Revenue by Type
4.2.1 Global Drugs for Facial Erythema Historical Revenue by Type (2017-2022)
4.2.2 Global Drugs for Facial Erythema Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drugs for Facial Erythema Revenue Market Share by Type (2017-2028)
4.3 Global Drugs for Facial Erythema Price by Type
4.3.1 Global Drugs for Facial Erythema Price by Type (2017-2022)
4.3.2 Global Drugs for Facial Erythema Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drugs for Facial Erythema Sales by Application
5.1.1 Global Drugs for Facial Erythema Historical Sales by Application (2017-2022)
5.1.2 Global Drugs for Facial Erythema Forecasted Sales by Application (2023-2028)
5.1.3 Global Drugs for Facial Erythema Sales Market Share by Application (2017-2028)
5.2 Global Drugs for Facial Erythema Revenue by Application
5.2.1 Global Drugs for Facial Erythema Historical Revenue by Application (2017-2022)
5.2.2 Global Drugs for Facial Erythema Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drugs for Facial Erythema Revenue Market Share by Application (2017-2028)
5.3 Global Drugs for Facial Erythema Price by Application
5.3.1 Global Drugs for Facial Erythema Price by Application (2017-2022)
5.3.2 Global Drugs for Facial Erythema Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drugs for Facial Erythema Market Size by Type
6.1.1 North America Drugs for Facial Erythema Sales by Type (2017-2028)
6.1.2 North America Drugs for Facial Erythema Revenue by Type (2017-2028)
6.2 North America Drugs for Facial Erythema Market Size by Application
6.2.1 North America Drugs for Facial Erythema Sales by Application (2017-2028)
6.2.2 North America Drugs for Facial Erythema Revenue by Application (2017-2028)
6.3 North America Drugs for Facial Erythema Market Size by Country
6.3.1 North America Drugs for Facial Erythema Sales by Country (2017-2028)
6.3.2 North America Drugs for Facial Erythema Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Drugs for Facial Erythema Market Size by Type
7.1.1 Europe Drugs for Facial Erythema Sales by Type (2017-2028)
7.1.2 Europe Drugs for Facial Erythema Revenue by Type (2017-2028)
7.2 Europe Drugs for Facial Erythema Market Size by Application
7.2.1 Europe Drugs for Facial Erythema Sales by Application (2017-2028)
7.2.2 Europe Drugs for Facial Erythema Revenue by Application (2017-2028)
7.3 Europe Drugs for Facial Erythema Market Size by Country
7.3.1 Europe Drugs for Facial Erythema Sales by Country (2017-2028)
7.3.2 Europe Drugs for Facial Erythema Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drugs for Facial Erythema Market Size by Type
8.1.1 Asia Pacific Drugs for Facial Erythema Sales by Type (2017-2028)
8.1.2 Asia Pacific Drugs for Facial Erythema Revenue by Type (2017-2028)
8.2 Asia Pacific Drugs for Facial Erythema Market Size by Application
8.2.1 Asia Pacific Drugs for Facial Erythema Sales by Application (2017-2028)
8.2.2 Asia Pacific Drugs for Facial Erythema Revenue by Application (2017-2028)
8.3 Asia Pacific Drugs for Facial Erythema Market Size by Region
8.3.1 Asia Pacific Drugs for Facial Erythema Sales by Region (2017-2028)
8.3.2 Asia Pacific Drugs for Facial Erythema Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drugs for Facial Erythema Market Size by Type
9.1.1 Latin America Drugs for Facial Erythema Sales by Type (2017-2028)
9.1.2 Latin America Drugs for Facial Erythema Revenue by Type (2017-2028)
9.2 Latin America Drugs for Facial Erythema Market Size by Application
9.2.1 Latin America Drugs for Facial Erythema Sales by Application (2017-2028)
9.2.2 Latin America Drugs for Facial Erythema Revenue by Application (2017-2028)
9.3 Latin America Drugs for Facial Erythema Market Size by Country
9.3.1 Latin America Drugs for Facial Erythema Sales by Country (2017-2028)
9.3.2 Latin America Drugs for Facial Erythema Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drugs for Facial Erythema Market Size by Type
10.1.1 Middle East and Africa Drugs for Facial Erythema Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drugs for Facial Erythema Revenue by Type (2017-2028)
10.2 Middle East and Africa Drugs for Facial Erythema Market Size by Application
10.2.1 Middle East and Africa Drugs for Facial Erythema Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drugs for Facial Erythema Revenue by Application (2017-2028)
10.3 Middle East and Africa Drugs for Facial Erythema Market Size by Country
10.3.1 Middle East and Africa Drugs for Facial Erythema Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drugs for Facial Erythema Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Drugs for Facial Erythema Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Drugs for Facial Erythema Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Drugs for Facial Erythema Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Drugs for Facial Erythema Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Overview
11.3.3 Sanofi-Aventis Drugs for Facial Erythema Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi-Aventis Drugs for Facial Erythema Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Aventis Recent Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Overview
11.4.3 Merck Drugs for Facial Erythema Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck Drugs for Facial Erythema Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Enzon Pharmaceuticals
11.5.1 Enzon Pharmaceuticals Corporation Information
11.5.2 Enzon Pharmaceuticals Overview
11.5.3 Enzon Pharmaceuticals Drugs for Facial Erythema Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Enzon Pharmaceuticals Drugs for Facial Erythema Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Enzon Pharmaceuticals Recent Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Overview
11.6.3 Bayer Drugs for Facial Erythema Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bayer Drugs for Facial Erythema Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Recent Developments
11.7 Astellas Pharma
11.7.1 Astellas Pharma Corporation Information
11.7.2 Astellas Pharma Overview
11.7.3 Astellas Pharma Drugs for Facial Erythema Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Astellas Pharma Drugs for Facial Erythema Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Astellas Pharma Recent Developments
11.8 GSK
11.8.1 GSK Corporation Information
11.8.2 GSK Overview
11.8.3 GSK Drugs for Facial Erythema Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GSK Drugs for Facial Erythema Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GSK Recent Developments
11.9 Abbott
11.9.1 Abbott Corporation Information
11.9.2 Abbott Overview
11.9.3 Abbott Drugs for Facial Erythema Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Abbott Drugs for Facial Erythema Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Abbott Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drugs for Facial Erythema Industry Chain Analysis
12.2 Drugs for Facial Erythema Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drugs for Facial Erythema Production Mode & Process
12.4 Drugs for Facial Erythema Sales and Marketing
12.4.1 Drugs for Facial Erythema Sales Channels
12.4.2 Drugs for Facial Erythema Distributors
12.5 Drugs for Facial Erythema Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drugs for Facial Erythema Industry Trends
13.2 Drugs for Facial Erythema Market Drivers
13.3 Drugs for Facial Erythema Market Challenges
13.4 Drugs for Facial Erythema Market Restraints
14 Key Findings in The Global Drugs for Facial Erythema Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer